Method and composition for treating intestinal wounds or ulcers

Details Method and composition for treating intestinal wounds or ulcers Method and composition for treating intestinal wounds or ulcers

1994-09-02

1996-11-26

Fleisher, Mindy

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 12, 514 23, 514925, 514926, 514927, 424439, A61K 3816, A61K 3801, A61K 3804, A61K 3170

Patent

active

055785760

ABSTRACT:
The present invention provides a method for aiding healing or preventing the onset of intestinal wounds or ulcers in a patient. In addition, the present invention provides a method for reducing, or preventing, the gastrointestinal side effects associated with the administration of a nonsteroidal anti-inflammatory drug. Pursuant to the present invention, the composition includes a protein source, a carbohydrate source, a fat source, and a specialized vitamin and mineral profile.

REFERENCES:
patent: 4414238 (1983-11-01), Schmidl
patent: 4847296 (1989-07-01), Babayan et al.
patent: 5214066 (1993-05-01), Szabo
patent: 5221668 (1993-06-01), Henningfield et al.
patent: 5223284 (1993-06-01), Kulczycki, Jr. et al.
patent: 5240909 (1993-08-01), Nitsche
Law et al. "The Effect of Dietary Protein Depletion on Immunocompetence" Ann Surg. 179(2) 168-173 1974.
Gitnick "Current Gastroenterology" pp. 32-49 1985.
Mulder, Food and animal feed additives containing manganese--to promote growth of intestinal lactic acid bacteria, e.g. for prophylaxis of diabetes, WPAT Abstracts, Abstract No. 93-203368/25.
Serhan et al, Use of lipoxin and its derivatives as antagonists for SRS-A especially LTD--for control of haemostasis, vasoconstriction, anaphylactic and allergic reactions in animals, WPAT Abstracts, Abstract No. 90-361242/48.
Brooks et al, New substd. furan and pyrrole cpds.--are inhibitors of 5- and/or 12-lipoxygenase activity which orally prevent in vivo biosynthesis of leukotriene(s), WPAT Abstracts, Abstract No. 89-165598/22.
Diamantstein et al, Monoclonal antibodies recognizing human interleukin-2 receptors--useful in therapy of hyperimmune syndrome diseases, for coupling to cytotoxic agents and in diagnosis of the receptors in or on cells, WPAT Abstracts, Abstract No. 87-286562/41.
Johnson et al, Extract of Tanacetium parthenium--containing sesqui:terpene lactone(s) for treating migraine and arthritic and bronchial disorders, WPAT Abstracts, Abstract No. 84-011818/03.
Ueda et al, Drug for Protecting Gastrointestinal Cell, JAPIO Abstracts, Abstract No. 85-013714.
Zimmermann et al, Insulin-like growth factor I and interleukin 1.beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis, Chemical Abstracts, Abstract No. CA119-223219(21).
Auler et al, Antibodies of IgG2 subtype are involved in the immunological inflammatory response of TNBS-induced enteritis in rats, Chemical Abstracts, Abstract No. CA119-070240(07).
Mitchell et al, Effect of the immune modulating agents cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on an animal model of granulomatous bowel disease, Chemical Abstracts, Abstract No. CA113-091119(11).
Wallace et al, An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis, Chemical Abstracts, Abstract No. CA113-034472(05).
Allison et al, Gastrointestinal Damage Associated With the Use of Nonsteroidal Antiinflammatory Drugs, The New England Journal of Medicine, vol. 327, No. 11, pp. 749-754 (1992).
Bjarnason et al, Clinicopathological Features of Nonsteroidal Antiinflammatory Drug-Induced Small Intestinal Strictures, Gastroenterology, vol. 94, No. 4, pp. 1070-1074 (1988).
Bjarnason et al, Nonsteroidal Antiinflammatory Drug-Induced Intestinal Inflammation in Humans, Gastroenterology, vol. 93, No. 3, pp. 480-489 (1987).
Fang et al, Indomethacin-Induced Intestinal Inflammation, Digestive Diseases, vol. 22, No. 9, pp. 749-760 (1977).
Matsumoto et al, Effects of diet on experimentally induced intestinal ulcers in rats: morphology and tissue leukotrienes, Gut, vol. 35, pp. 1058-1063 (1994).
Alder et al, Enteral Formula Composition Does Not Affect Response to Lethal Infectious Challenge in Mice, J. Nutr., vol. 124, pp. 2156-2162 (1994).

Affiliated with

Also associated with

Rating

Method and composition for treating intestinal wounds or ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for treating intestinal wounds or ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating intestinal wounds or ulcers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1973185